Who has invested in Eagle Genomics?

Environmental Technologies Fund, abrdn, Omron are named among the investors backing Eagle Genomics.

Eagle Genomics Funding: $43M Raised, Series D (2022)

Eagle Genomics funding overview

Eagle Genomics is based in Hinxton, Cambridgeshire, United Kingdom. Eagle Genomics has raised $43M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series D announced in January 2022. The round record for Eagle Genomics runs through 2022; nothing later has been disclosed. Investors on record include Environmental Technologies Fund, abrdn, Omron. 3 distinct backers are named across the disclosed rounds.

Eagle Genomics at a glance

Total raised: $43M
Latest round: Series D
Latest round date: January 2022
Headquarters: Hinxton, Cambridgeshire, United Kingdom
Notable investors: Environmental Technologies Fund, abrdn, Omron

Frequently asked about Eagle Genomics funding

How much has Eagle Genomics raised?: Eagle Genomics has raised $43M in total disclosed funding across the rounds on record.
Who has invested in Eagle Genomics?: Environmental Technologies Fund, abrdn, Omron are named among the investors backing Eagle Genomics.
What was the latest Eagle Genomics funding round?: The most recent disclosed round is a Series D, announced in January 2022.
Where is Eagle Genomics based?: Eagle Genomics is based in Hinxton, Cambridgeshire, United Kingdom.
When did Eagle Genomics last raise?: The last disclosed Eagle Genomics round closed in January 2022 at Series D.

Eagle Genomics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Hinxton below to benchmark round size and investor mix.

Eagle Genomics Funding: $43M Raised, Series D (2022)

Eagle Genomics funding overview

Eagle Genomics at a glance

Frequently asked about Eagle Genomics funding

Companies related to Eagle Genomics (30)

Browse related funding lists (3)